POLYNOVO LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.99 AUD | -4.78% |
|
+2.31% | +20.24% |
| Mar. 04 | Polynovo Gets India OK for Listing of Dermal Scaffold Device on Government e-Portal Marketplace | MT |
| Feb. 27 | Transcript : PolyNovo Limited, H1 2024 Earnings Call, Feb 27, 2024 |
Valuation
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,018 | 1,679 | 1,865 | 896.6 | 1,066 | 1,374 | - | - |
| Enterprise Value (EV) 1 | 1,004 | 1,675 | 1,867 | 894.6 | 1,023 | 1,331 | 1,337 | 1,328 |
| P/E ratio | -321 x | -403 x | -409 x | -753 x | -215 x | 330 x | 102 x | 56.7 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 70.8 x | 75.6 x | 63.7 x | 21.4 x | 16 x | 13.4 x | 10.3 x | 8.23 x |
| EV / Revenue | 69.8 x | 75.4 x | 63.7 x | 21.4 x | 15.4 x | 13 x | 10 x | 7.95 x |
| EV / EBITDA | -349 x | -523 x | -566 x | 420 x | -469 x | 323 x | 88.7 x | 44.8 x |
| EV / FCF | -102 x | -180 x | -489 x | -351 x | -126 x | 4,753 x | -326 x | 172 x |
| FCF Yield | -0.98% | -0.56% | -0.2% | -0.28% | -0.8% | 0.02% | -0.31% | 0.58% |
| Price to Book | 39 x | 70.5 x | 83.4 x | 50.6 x | 16.3 x | 19.5 x | 17 x | 11.5 x |
| Nbr of stocks (in thousands) | 661,088 | 661,088 | 661,388 | 661,688 | 690,233 | 690,233 | - | - |
| Reference price 2 | 1.540 | 2.540 | 2.820 | 1.355 | 1.545 | 1.990 | 1.990 | 1.990 |
| Announcement Date | 8/21/19 | 8/26/20 | 8/25/21 | 8/26/22 | 8/23/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 14.38 | 22.2 | 29.3 | 41.89 | 66.54 | 102.7 | 133.3 | 166.9 |
| EBITDA 1 | -2.88 | -3.2 | -3.3 | 2.129 | -2.181 | 4.119 | 15.07 | 29.62 |
| EBIT 1 | -3.19 | -4 | -4.2 | 0.5402 | -4.219 | 2.723 | 13.55 | 27 |
| Operating Margin | -22.19% | -18.02% | -14.33% | 1.29% | -6.34% | 2.65% | 10.16% | 16.17% |
| Earnings before Tax (EBT) 1 | -3.19 | -4.1 | -4.55 | -1.151 | -4.933 | 2.651 | 14.7 | 28.62 |
| Net income 1 | -3.19 | -4.2 | -4.605 | -1.193 | -4.925 | 3.761 | 13.15 | 24.48 |
| Net margin | -22.19% | -18.92% | -15.72% | -2.85% | -7.4% | 3.66% | 9.86% | 14.67% |
| EPS 2 | -0.004800 | -0.006300 | -0.006900 | -0.001800 | -0.007200 | 0.006030 | 0.0196 | 0.0351 |
| Free Cash Flow 1 | -9.89 | -9.297 | -3.819 | -2.549 | -8.141 | 0.28 | -4.1 | 7.74 |
| FCF margin | -68.79% | -41.88% | -13.03% | -6.08% | -12.24% | 0.27% | -3.08% | 4.64% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 6.8% | - | 26.13% |
| FCF Conversion (Net income) | - | - | - | - | - | 7.45% | - | 31.62% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 8/21/19 | 8/26/20 | 8/25/21 | 8/26/22 | 8/23/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q3 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12.6 | 16.7 | 18.1 | 11.9 | 23.79 | 29.37 | - | 48.76 | 55.3 |
| EBITDA | - | - | -1.573 | - | - | - | 0.5894 | 2.493 | 4.5 |
| EBIT | -1.906 | -2.294 | -2.322 | - | -2.39 | -3.759 | -0.4598 | 1.451 | 5.2 |
| Operating Margin | -15.12% | -13.74% | -12.83% | - | -10.05% | -12.8% | - | 2.98% | 9.4% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - |
| Net income | - | - | 1.619 | - | -2.811 | -3.824 | -1.101 | - | 0.9 |
| Net margin | - | - | 8.94% | - | -11.82% | -13.02% | - | - | 1.63% |
| EPS | - | - | 0.002400 | - | -0.004200 | - | - | - | 0.001000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/22/21 | 8/25/21 | 2/24/22 | 5/26/22 | 8/26/22 | 2/22/23 | 8/23/23 | 2/27/24 | - |
1AUD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 2.31 | - | - | - | - | - |
| Net Cash position 1 | 14 | 4.41 | - | 1.97 | 43.7 | 42.6 | 37.1 | 45.8 |
| Leverage (Debt/EBITDA) | - | - | -0.6995 x | - | - | - | - | - |
| Free Cash Flow 1 | -9.89 | -9.3 | -3.82 | -2.55 | -8.14 | 0.28 | -4.1 | 7.74 |
| ROE (net income / shareholders' equity) | -11.7% | -17.4% | -20% | -5.95% | -11.9% | 5.37% | 15.5% | 23.1% |
| ROA (Net income/ Total Assets) | -11% | -13.2% | -12.1% | -3.25% | -7.72% | 5.55% | 13.2% | 19.8% |
| Assets 1 | 29.03 | 31.93 | 38.1 | 36.66 | 63.8 | 67.76 | 99.79 | 123.6 |
| Book Value Per Share 2 | 0.0400 | 0.0400 | 0.0300 | 0.0300 | 0.0900 | 0.1000 | 0.1200 | 0.1700 |
| Cash Flow per Share 2 | -0.0500 | -0.0100 | -0 | -0 | -0.0100 | 0 | 0.0200 | 0.0400 |
| Capex 1 | - | 8.87 | 3.57 | 0.49 | 1.53 | 2.46 | 13.4 | 15.5 |
| Capex / Sales | - | 39.95% | 12.18% | 1.17% | 2.3% | 2.4% | 10.02% | 9.29% |
| Announcement Date | 8/21/19 | 8/26/20 | 8/25/21 | 8/26/22 | 8/23/23 | - | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
1.99
AUD
Average target price
2.113
AUD
Spread / Average Target
+6.20%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.24% | 896M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- PNV Stock
- Financials PolyNovo Limited
